Of the 20 cases for which methylation and expression were available for both the tumour and matched normal tissues, HOPX was lower in 17 (85%) of cases; 3 of the 17 tumours showed evidence of HOPX-β promoter hyper-methylation and this was associated with a significant reduction of expression (Fig. 3C). Here, HOPX is linked to neoplasm.